Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: life extension – Page 524

Dr. David Sinclair AMA at Reddit Futurology

In support of the NAD+ Mouse Project over at Lifespan.io, Dr. David Sinclair will be doing an AMA on Reddit Futurology Tuesday, October 23, 2018 from 11:00 – 12:00 AM EDT. Dr. Sinclair will be answering questions from the community about his work with NAD+ biology, Sirtuins, and why the NAD+ Mouse Project is important for aging research. To ask your question please visit the AMA thread on Reddit Futurology here.

For those not familiar with NAD+ biology we did the NAD+ World series recently which explores this area of the biology of aging. We also took a look at why NAD+ appears to decline as we age and what is one of the most likely reasons for this.

Dr. Sinclair and his team at Harvard Medical School are currently hosting the NAD+ Mouse Project with us at Lifespan.io which is aiming to conduct long-term studies into the ability of NAD+ precursor molecule, NMN, to delay or even reverse some aspects of aging.

Joe Betts Lacroix – Entrepreneurial Focuses on Aging

Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union, New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Joe Betts Lacroix of Y Combinator and Vium discusses the different ways in which entrepreneurs can focus on overcoming the diseases of aging, namely direct, indirect, and money-first approaches, and the strengths and weakness of each.

Joe was the primary technical founder of hardware/software startup OQO, which entered the Guinness Book of World Records for building the smallest fully featured PC. His experience spans from biotech research to electronics design. Very experienced in invention, prosecution and monetization of intellectual property, he has over 80 patents granted and pending in fields ranging from biophysics and safety systems to antennas, thermal systems, user interfaces, and analog electronics. He has written numerous peer-reviewed publications in fields such as biophysics, genetics, electronics, and robotics. Joe holds a Harvard A.B., an MIT S.M. and a Caltech research fellowship.

Humans beings on the brink of IMMORTALITY, top scientist claims

Two of the methods he said humans might use were “body part renewal” and linking bodies with machines so that people are living their lives through an android.

But after Dr Pearson’s predictions, immortality may now be a step nearer following the launch of a new start-up.

Human is hoping to make the immortality dream a reality with an ambitious plan.

Dr. James Peyer – A Portfolio Approach To Longevity

Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Dr. James Peyer is the founder and Managing Partner of Apollo Ventures, an early-stage life science investor and company builder that focuses on breakthrough technologies for treating age-related diseases.

He discusses the strategic paths to bringing longevity-promoting therapeutics to market as quickly as possible, with a particular focus on engaging pharmaceutical companies via disease-focused, proof-of-concept trials.

The Longevity Project: Surprising Discoveries for Health and Long Life from the Landmark Eight-Decade Study: Howard S. Friedman, Leslie R. Martin: 9780452297708: Amazon.com: Books

“An extraordinary eighty-year study has led to some unexpected discoveries about long life.”

-O, The Oprah Magazine

For years we have been told to obsessively monitor when we’re angry, what we eat, how much we worry, and how often we go to the gym. So why isn’t everyone healthy? Drawing from the most extensive study of long life ever conducted, The Longevity Project busts many long- held myths, revealing how:

Startups in the Aging Sector — Ending Age-Related Diseases 2018

Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union in New York City. This conference was designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Dr. Oliver Medvedik, LEAF vice president and Director of the Maurice Kanbar Center for Biomedical Engineering at the Cooper Union, chaired a panel with a focus on starting up biotech companies and dealing with the challenges inherent to launching a company in this industry.

/* */